亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

High-Dose TSLP Induces Co-Receptor Internalization and Signal Shutdown in Ph-like B-ALL with Overexpression of CRLF2

流式细胞术 白血病 癌症研究 受体 细胞因子 蛋白激酶B 免疫学 内化 PI3K/AKT/mTOR通路 信号转导 医学 化学 生物 内科学 细胞生物学
作者
WayAnne B. Watson,Hossam R. Alkashgari,Cornelia Stoian,Jacqueline S. Coats,Ineavely Báez,Hannah S. J. Choi,Benjamin J. Becerra,Rishikesh S. Chavan,Muhammad Omair Kamal,Shadi Farzin Gohar,Xianmei Meng,Sinisa Dovat,Kimberly J. Payne,Hoda Erjaee
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 4024-4024
标识
DOI:10.1182/blood-2018-99-114336
摘要

Abstract Background. Approximately half of all Ph-like B cell acute lymphoblastic leukemia is characterized by overexpression of CRLF2 (CRLF2 B-ALL). CRLF2 B-ALL is associated with high rates of relapse and is more prevalent in Hispanic children with Native American ancestry. CRLF2, together with the IL-7 receptor alpha (IL-7Ra), comprises a receptor complex that is activated by the cytokine, TSLP. Receptor activation by TSLP induces JAK2/STAT5 and PI3/AKT/mTOR signals that promote survival and proliferation of leukemia cells. To study the role of TSLP in CRLF2 B-ALL, we developed a patient-derived xenograft (PDX) model of CRLF2 B-ALL that allows us to vary circulating levels of human TSLP (hTSLP) in a physiologic environment. We generated PDX from patients' CRLF2 B-ALL cells and compared leukemia burden in mice with varying levels of hTSLP. CRLF2 B-ALL cells grew robustly in PDX models with hTSLP levels at or below levels present in pediatric cancer patients (~10 pg/mL). In contrast, CRLF2 B-ALL cells were essentially eliminated in PDXs with hTSLP at high physiological levels (40-140 pg/mL). These data suggest that high physiologic levels of TSLP exert a potent anti-leukemia effect in Ph-like B-ALL with overexpression of CRLF2. Objective. The objective of the proposed research was to evaluate potential mechanisms of TSLP's anti-leukemia effects. Research Design/Methods. TSLP dose response studies were performed and flow cytometry was used to evaluate the effect of TSLP on CRLF2 signaling, surface expression of TSLP receptor components (IL-7Ra and CRLF2) and expression of the Suppressor of Cytokine Signaling (SOCS) proteins in CRLF2 B-ALL cell lines (MUTZ5 and CALL-4) and CRLF2 B-ALL cells from Hispanic pediatric patients. Whole genome microarray was used to evaluate TSLP effects on SOCS gene expression in patient samples. Results. CRLF2 B-ALL cell lines cultured with TSLP showed a dose-dependent loss in the ability to induce phosphorylation of STAT5 and S6 (downstream of PI3/AKT/mTOR) following TSLP stimulation. This loss was correlated with a complete loss of surface IL-7Ra, and maintained for 24-48 hours following a pulse of high-dose, but not low-dose, hTSLP. The loss of surface CRLF2 was minimal. The loss of signaling and surface IL-7Ra could be prolonged if high-dose hTSLP levels were maintained. Similarly, preliminary studies of CRLF2 B-ALL cells from pediatric patients showed a loss of surface IL-7Ra following culture with high-dose TSLP. A potential mechanism for the effects of high-dose TSLP are the suppressor of cytokine signaling (SOCS) genes. These genes encode a family of proteins (SOCS1-7 and CISH) that regulate cytokine signaling via negative feedback through multiple mechanisms including ubiquitin-mediated cytokine receptor degradation. Whole genome microarray showed that SOCS1, SOCS2, SOCS3 and CISH mRNA are upregulated in patient CRLF2 B-ALL cells cultured with high-dose TSLP. Flow cytometry analysis showed that high-dose TSLP upregulates SOCS1 and SOCS3 proteins in CRLF2 B-ALL cell lines and in patient samples. Conclusion. These data provide evidence that TSLP exerts anti-leukemia effects by shutting down CRLF2-mediated signals and that these effects are at least partially mediated by the loss of the IL-7Ra component, and potentially through SOCS family proteins. These studies identify the human TSLP cytokine as a potential biologic therapy to treat CRLF2 B-ALL. Supported in part by 1R01CA209829 (KJP and SD), 1R43CA224723 (XM and KJP), ASH HONORS Award 2018-2019 (WBW), and Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship 2018-2019 (WBW). Disclosures Coats: Elf Zone, Inc.: Consultancy, Membership on an entity's Board of Directors or advisory committees. Meng:Elf Zone, Inc.: Employment. Dovat:Elf Zone, Inc.: Membership on an entity's Board of Directors or advisory committees. Payne:Elf Zone, Inc.: Consultancy, Equity Ownership, Membership on an entity's Board of Directors or advisory committees.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
隐形荟完成签到 ,获得积分10
12秒前
15秒前
舒适的夜柳完成签到,获得积分10
15秒前
kevin完成签到 ,获得积分10
24秒前
31秒前
orixero的应助被五岁的哈士奇采纳,获得10
32秒前
33秒前
YuxinChen完成签到 ,获得积分10
39秒前
快乐的稚晴完成签到,获得积分10
45秒前
57秒前
小蘑菇的应助被科研通管家采纳,获得10
57秒前
1分钟前
闪闪雍完成签到,获得积分10
1分钟前
1分钟前
健忘的小萱完成签到,获得积分10
1分钟前
玩命的芸遥完成签到,获得积分10
1分钟前
Andrew发布了新的文献求助10
1分钟前
Andrew完成签到,获得积分10
2分钟前
2分钟前
2分钟前
wanci的应助被五岁的哈士奇采纳,获得10
2分钟前
魔幻雪兰完成签到,获得积分10
2分钟前
奋斗的听露完成签到,获得积分10
2分钟前
霸气的似狮完成签到,获得积分10
3分钟前
听话的秋白完成签到,获得积分10
3分钟前
Hello的应助被YYY采纳,获得10
3分钟前
hupo完成签到,获得积分10
3分钟前
含蓄的雪冥完成签到,获得积分10
3分钟前
4分钟前
高高的仇血完成签到,获得积分10
4分钟前
朴实傲白完成签到 ,获得积分10
4分钟前
4分钟前
欢呼的兰完成签到,获得积分10
4分钟前
4分钟前
MT发布了新的文献求助10
4分钟前
soleil关注了科研通微信公众号
4分钟前
贪玩醉薇完成签到,获得积分10
4分钟前
4分钟前
leoo完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179920
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808354
捐赠科研通 7775701
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918